Across hospitals in Germany, diabetes clinics in Saudi Arabia, laboratories in the UK, and healthcare centers in South Africa, safety lancets are becoming an important part of routine blood testing.
For many years, traditional lancets were commonly used for glucose testing and blood sample collection. While they were inexpensive and easy to use, they also increased the risk of accidental needle-stick injuries and cross-contamination in healthcare settings.
Healthcare providers across Europe, the Middle East, and Africa are now shifting toward safety lancets because they offer better protection for both patients and medical staff. These devices automatically retract after use, helping reduce direct contact with needles and lowering infection risks.
The market is growing steadily due to rising diabetes cases, stricter healthcare safety standards, and increasing demand for home-based testing.
Europe currently represents more than 34% of the global safety lancet market. In 2025, the European market was valued at nearly USD 0.78 billion and is expected to continue expanding over the next several years.
Rising Diabetes Cases Are Increasing Daily Testing
The growing number of diabetes patients is one of the main reasons behind the increasing demand for safety lancets.
Europe has more than 61 million adults living with diabetes, while countries such as Saudi Arabia and the UAE continue to report rising diabetes prevalence. Many patients require blood glucose testing multiple times each day, creating continuous demand for disposable lancets.
As diabetes management becomes more common in homecare settings, pharmacies and healthcare providers are also increasing the supply of single-use safety devices that are easier and safer for patients to handle independently.
This growing demand has made safety lancets an essential product across hospitals, clinics, laboratories, and home healthcare systems.
Hospitals Are Prioritizing Infection Prevention
Healthcare facilities across Europe are placing greater attention on infection control and workplace safety.
Nurses, laboratory technicians, and healthcare workers perform thousands of blood collection procedures every day. Even a small number of accidental needle injuries can create serious health risks and increase operational costs for hospitals.
Safety lancets help reduce these risks because the needle retracts immediately after use. This lowers the chances of accidental reuse and direct needle exposure.
Countries such as Germany, France, and the UK have seen strong adoption of safety-engineered blood collection devices due to strict healthcare regulations. At the same time, Middle Eastern healthcare systems are investing heavily in modern diagnostic infrastructure and preventive healthcare services.
EMEA Safety Lancet Market Snapshot
| Category | Data |
|---|---|
| Europe safety lancet market share | 34%+ of global market |
| Europe market value (2025) | USD 0.78 billion |
| Expected market growth rate | 10.2% CAGR |
| Adults living with diabetes in Europe | 61+ million |
| BD estimated market share | 20%–22% |
| Roche total company sales (2024) | CHF 60+ billion |
| HTL-STREFA annual safety lancet sales | 691+ million units |
| HTL-STREFA personal lancet sales | 942+ million units |
| Major growth regions | Germany, UK, France, Saudi Arabia, UAE, South Africa |
| Fastest-growing segment | Home healthcare testing |
Becton Dickinson Holds a Strong Position in the Market
Becton, Dickinson and Company is one of the largest companies operating in the safety lancet industry.
The company generates annual revenue of more than USD 20 billion and has a strong presence in blood collection systems, diabetes care products, hospital consumables, and medical safety devices.
Its safety lancets are widely used in hospitals and laboratories because of their reliability and ease of use in high-volume healthcare environments.
Industry estimates indicate that BD holds around 20% to 22% share of the global lancet and blood sampling market.
Roche Expanded Through Diabetes Care Products
Roche Diagnostics has strengthened its market presence through diabetes monitoring products.
Its Accu-Chek portfolio is widely used across Europe and the Middle East for blood glucose monitoring and self-testing. The company reported total sales exceeding CHF 60 billion in 2024, supported by strong demand for diagnostics and diabetes care products.
Roche has benefited from the increasing shift toward home healthcare, where patients prefer simple and less painful testing devices for regular glucose monitoring.
The company continues to focus on connected diabetes care systems and patient-friendly blood testing solutions.
HTL-STREFA Built Large-Scale Manufacturing Capacity
HTL-STREFA has become one of the major manufacturing companies in the safety lancet industry.
The company previously reported annual sales of more than 691 million safety lancets and over 942 million personal lancets. It also supplies products to several global healthcare and diabetes care brands.
Its large manufacturing capacity has helped meet rising demand across Europe and other international markets.
Home Healthcare Is Supporting Long-Term Market Growth
One of the biggest changes in the market is the rise of home-based glucose monitoring.
Many elderly patients and diabetes patients now prefer testing their blood sugar levels at home using portable glucose meters and disposable safety lancets. Healthcare providers are also encouraging remote monitoring to reduce hospital visits and improve long-term disease management.
This trend is increasing demand for compact, painless, and easy-to-use lancets designed for personal use.
As healthcare systems continue focusing on preventive care and patient safety, demand for safety lancets across Europe, the Middle East, and Africa is expected to remain strong.
Get Easy Access
Imagine having all the insights you need about the Safety Lancet Market/ Medical Devices Sector in one intuitive platform. Our experts have crafted a dashboard where statistical data, country insights, competitor strategies, and emerging trends come together seamlessly. Analyze, compare, and plan your next move without switching between reports or spreadsheets. Visit and access the dashboard today; make informed decisions with confidence.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting delivers strategic insights across the medical devices market, including diagnostic devices, surgical equipment, imaging systems, wearable technologies, cardiovascular devices, and orthopedic implants. We help healthcare innovators track market trends, optimize product strategies, and drive growth through data-driven intelligence and industry expertise.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium